Literature DB >> 18550889

Tumor versus tumor-associated macrophages: how hot is the link?

C Guruvayoorappan1.   

Abstract

One of the functions of macrophages is to provide a defense mechanism against tumor cells. In contrast, tumor-associated macrophages (TAMs), which represent the major inflammatory component of the stroma of many tumors, are associated with tumor progression and metastasis. TAMs, in contrast with normal macrophages, exhibit the M2 phenotype, and thereby exhibit pro-tumoral functions, including angiogenesis and matrix remodeling. This review will discuss the role of TAMs in tumor progression and provide an overview of their significant part in tumor metastasis and angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18550889     DOI: 10.1177/1534735408319060

Source DB:  PubMed          Journal:  Integr Cancer Ther        ISSN: 1534-7354            Impact factor:   3.279


  26 in total

Review 1.  Myeloid-derived suppressor cells in transplantation and cancer.

Authors:  Jordi C Ochando; Shu Hsia Chen
Journal:  Immunol Res       Date:  2012-12       Impact factor: 2.829

2.  Reciprocal regulation of activating and inhibitory Fc{gamma} receptors by TLR7/8 activation: implications for tumor immunotherapy.

Authors:  Jonathan P Butchar; Payal Mehta; Steven E Justiniano; Kristan D Guenterberg; Sri-Vidya Kondadasula; Xiaokui Mo; Mahesh Chemudupati; Thirumala-Devi Kanneganti; Amal Amer; Natarajan Muthusamy; David Jarjoura; Clay B Marsh; William E Carson; John C Byrd; Susheela Tridandapani
Journal:  Clin Cancer Res       Date:  2010-03-23       Impact factor: 12.531

3.  Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells.

Authors:  Ge Ma; Ping-Ying Pan; Samuel Eisenstein; Celia M Divino; Clifford A Lowell; Toshiyuki Takai; Shu-Hsia Chen
Journal:  Immunity       Date:  2011-03-03       Impact factor: 31.745

4.  Recruitment of monocytes and epigenetic silencing of intratumoral CYP7B1 primarily contribute to the accumulation of 27-hydroxycholesterol in breast cancer.

Authors:  Shui-Zhen Shi; Eun-Joon Lee; Ying-Jiong Lin; Lu Chen; Huai-Yu Zheng; Xiang-Qin He; Jing-Yi Peng; Satish K Noonepalle; Austin Y Shull; Felix C Pei; Li-Bin Deng; Xiao-Li Tian; Ke-Yu Deng; Huidong Shi; Hong-Bo Xin
Journal:  Am J Cancer Res       Date:  2019-10-01       Impact factor: 6.166

5.  Toll-like receptor 2 signaling protects mice from tumor development in a mouse model of colitis-induced cancer.

Authors:  Emily L Lowe; Timothy R Crother; Shervin Rabizadeh; Bing Hu; Hanlin Wang; Shuang Chen; Kenichi Shimada; Michelle H Wong; Kathrin S Michelsen; Moshe Arditi
Journal:  PLoS One       Date:  2010-09-27       Impact factor: 3.240

6.  Ecological therapy for cancer: defining tumors using an ecosystem paradigm suggests new opportunities for novel cancer treatments.

Authors:  Kenneth J Pienta; Natalie McGregor; Robert Axelrod; David E Axelrod
Journal:  Transl Oncol       Date:  2008-12       Impact factor: 4.243

Review 7.  Immune system: a double-edged sword in cancer.

Authors:  Bodduluru Lakshmi Narendra; Kasala Eshvendar Reddy; Saladi Shantikumar; Sistla Ramakrishna
Journal:  Inflamm Res       Date:  2013-07-19       Impact factor: 4.575

8.  Leukocytic promotion of prostate cellular proliferation.

Authors:  Kristy L McDowell; Lesa A Begley; Nirit Mor-Vaknin; David M Markovitz; Jill A Macoska
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

9.  Macrophages and inflammatory mediators in chemical toxicity: a battle of forces.

Authors:  Debra L Laskin
Journal:  Chem Res Toxicol       Date:  2009-08       Impact factor: 3.739

10.  Stromal regulatory T-cells are associated with a favourable prognosis in gastric cancer of the cardia.

Authors:  Matthias Haas; Arno Dimmler; Werner Hohenberger; Gerhard G Grabenbauer; Gerald Niedobitek; Luitpold V Distel
Journal:  BMC Gastroenterol       Date:  2009-09-04       Impact factor: 3.067

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.